Anti-KLH Polyclonal Antibody
Product Specifications
Background
Denosumab with trade name Prolia, is an FDA-approved drug for the treatment of patients with osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Denosumab is a fully human monoclonal antibody that works as a RANK ligand (RANKL) inhibitor. Denosumab can bind RANKL, preventing RANKL from activating RANK, its receptor on the osteoclast surface.
Host
Rabbit
Immunogen
Native Keyhole Limpet Hemocyanin (KLH) .
Target
Keyhole Limpet Hemocyanin, KLH
Clonality
Polyclonal
Applications
ELISA, WB
Purification
Purified by antigen affinity column.
Form
Liquid
Buffer
0.01M PBS, pH 7.4,50% Glycerol, 0.05% Proclin 300.
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Notes
For research use only. Not suitable for clinical or therapeutic use.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
